Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.

Lund LH. et al, (2024), Eur J Heart Fail

Extending mechanical thrombectomy service provision to 24/7: a break-even analysis.

Balami JS. et al, (2024), BMC Health Serv Res, 24

The societal economic impact of vision impairment in adults 40 years and above: findings from the National Eye Survey of Trinidad and Tobago.

Braithwaite T. et al, (2024), Eye (Lond), 38, 2124 - 2133

Minimal clinically important differences in patient-reported outcomes after coronary artery bypass surgery in the arterial revascularization trial.

Masterson Creber R. et al, (2024), Eur J Cardiothorac Surg, 66

Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.

Walli-Attaei M. et al, (2024), Europace, 26

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.

Mihaylova B. et al, (2024), Lancet Reg Health Eur, 40

Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.

Wu R. et al, (2024), Br J Gen Pract, 74, e189 - e198

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.

Morrow LM. et al, (2024), J Diabetes, 16

Statistical analysis plan for a cluster randomised controlled trial to compare screening, feedback and intervention for child anxiety problems to usual school practice: identifying Child Anxiety Through Schools-identification to intervention (iCATS-i2i).

Ball S. et al, (2024), Trials, 25

Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries.

Luengo-Fernandez R. et al, (2024), Eur Heart J Qual Care Clin Outcomes, 10, 36 - 44

Economic burden of cardiovascular diseases in the European Union: a population-based cost study.

Luengo-Fernandez R. et al, (2023), Eur Heart J, 44, 4752 - 4767

Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.

Lui JNM. et al, (2023), J Am Heart Assoc, 12

Bilateral versus single internal thoracic coronary artery bypass grafting: the ART RCT

Flather M. et al, (2023), Efficacy and Mechanism Evaluation, 1 - 20

Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in Scotland.

Thalmann I. et al, (2023), BMJ Qual Saf

Influence of diabetes and obesity on ten-year outcomes after coronary artery bypass grafting in the arterial revascularisation trial.

Stefil M. et al, (2023), Clin Res Cardiol

The multifaceted consequences and economic costs of child anxiety problems: A systematic review and meta-analysis.

Pollard J. et al, (2023), JCPP Adv, 3

Association between sternal wound complications and 10-year mortality following coronary artery bypass grafting.

Gaudino M. et al, (2023), J Thorac Cardiovasc Surg, 166, 532 - 539.e4

Coronary artery bypass grafting using bilateral internal thoracic arteries in patients with diabetes and obesity: A systematic review and meta-analysis.

Stefil M. et al, (2023), Int J Cardiol Heart Vasc, 47

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Zhou J. et al, (2023), Pharmacoeconomics, 41, 547 - 559

Load More

Include forthcoming?